RT Journal Article
SR Electronic
T1 Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.21.21268143
DO 10.1101/2021.12.21.21268143
A1 Karthikeyan, Smruthi
A1 Levy, Joshua I
A1 De Hoff, Peter
A1 Humphrey, Greg
A1 Birmingham, Amanda
A1 Jepsen, Kristen
A1 Farmer, Sawyer
A1 Tubb, Helena M.
A1 Valles, Tommy
A1 Tribelhorn, Caitlin E
A1 Tsai, Rebecca
A1 Aigner, Stefan
A1 Sathe, Shashank
A1 Moshiri, Niema
A1 Henson, Benjamin
A1 Mark, Adam M.
A1 Hakim, Abbas
A1 Baer, Nathan A
A1 Barber, Tom
A1 Belda-Ferre, Pedro
A1 Chacón, Marisol
A1 Cheung, Willi
A1 Cresini, Evelyn S
A1 Eisner, Emily R
A1 Lastrella, Alma L
A1 Lawrence, Elijah S
A1 Marotz, Clarisse A
A1 Ngo, Toan T
A1 Ostrander, Tyler
A1 Plascencia, Ashley
A1 Salido, Rodolfo A
A1 Seaver, Phoebe
A1 Smoot, Elizabeth W
A1 McDonald, Daniel
A1 Neuhard, Robert M
A1 Scioscia, Angela L
A1 Satterlund, Alysson M.
A1 Simmons, Elizabeth H
A1 Abelman, Dismas B.
A1 Brenner, David
A1 Bruner, Judith C.
A1 Buckley, Anne
A1 Ellison, Michael
A1 Gattas, Jeffrey
A1 Gonias, Steven L.
A1 Hale, Matt
A1 Hawkins, Faith
A1 Ikeda, Lydia
A1 Jhaveri, Hemlata
A1 Johnson, Ted
A1 Kellen, Vince
A1 Kremer, Brendan
A1 Matthews, Gary
A1 McLawhon, Ronald W.
A1 Ouillet, Pierre
A1 Park, Daniel
A1 Pradenas, Allorah
A1 Reed, Sharon
A1 Riggs, Lindsay
A1 Sanders, Alison
A1 Sollenberger, Bradley
A1 Song, Angela
A1 White, Benjamin
A1 Winbush, Terri
A1 Aceves, Christine M
A1 Anderson, Catelyn
A1 Gangavarapu, Karthik
A1 Hufbauer, Emory
A1 Kurzban, Ezra
A1 Lee, Justin
A1 Matteson, Nathaniel L
A1 Parker, Edyth
A1 Perkins, Sarah A
A1 Ramesh, Karthik S
A1 Robles-Sikisaka, Refugio
A1 Schwab, Madison A
A1 Spencer, Emily
A1 Wohl, Shirlee
A1 Nicholson, Laura
A1 Mchardy, Ian H
A1 Dimmock, David P
A1 Hobbs, Charlotte A
A1 Bakhtar, Omid
A1 Harding, Aaron
A1 Mendoza, Art
A1 Bolze, Alexandre
A1 Becker, David
A1 Cirulli, Elizabeth T
A1 Isaksson, Magnus
A1 Schiabor Barrett, Kelly M
A1 Washington, Nicole L
A1 Malone, John D
A1 Schafer, Ashleigh Murphy
A1 Gurfield, Nikos
A1 Stous, Sarah
A1 Fielding-Miller, Rebecca
A1 Garfein, Richard S.
A1 Gaines, Tommi
A1 Anderson, Cheryl
A1 Martin, Natasha K.
A1 Schooley, Robert
A1 Austin, Brett
A1 MacCannell, Duncan R.
A1 Kingsmore, Stephen F
A1 Lee, William
A1 Shah, Seema
A1 McDonald, Eric
A1 Yu, Alexander T.
A1 Zeller, Mark
A1 Fisch, Kathleen M
A1 Longhurst, Christopher
A1 Maysent, Patty
A1 Pride, David
A1 Khosla, Pradeep K.
A1 Laurent, Louise C.
A1 Yeo, Gene W
A1 Andersen, Kristian G
A1 Knight, Rob
YR 2022
UL http://medrxiv.org/content/early/2022/04/04/2021.12.21.21268143.abstract
AB As SARS-CoV-2 continues to spread and evolve, detecting emerging variants early is critical for public health interventions. Inferring lineage prevalence by clinical testing is infeasible at scale, especially in areas with limited resources, participation, or testing/sequencing capacity, which can also introduce biases. SARS-CoV-2 RNA concentration in wastewater successfully tracks regional infection dynamics and provides less biased abundance estimates than clinical testing. Tracking virus genomic sequences in wastewater would improve community prevalence estimates and detect emerging variants. However, two factors limit wastewater-based genomic surveillance: low-quality sequence data and inability to estimate relative lineage abundance in mixed samples. Here, we resolve these critical issues to perform a high-resolution, 295-day wastewater and clinical sequencing effort, in the controlled environment of a large university campus and the broader context of the surrounding county. We develop and deploy improved virus concentration protocols and deconvolution software that fully resolve multiple virus strains from wastewater. We detect emerging variants of concern up to 14 days earlier in wastewater samples, and identify multiple instances of virus spread not captured by clinical genomic surveillance. Our study provides a scalable solution for wastewater genomic surveillance that allows early detection of SARS-CoV-2 variants and identification of cryptic transmission.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.protocols.io/view/high-throughput-wastewater-sars-cov-2-detection-pi-bshvnb66 Funding StatementThis work has been funded by CDC BAA contracts 75D30121P10258 (Helix) and 75D30120C09795 (G.W.Y., R.K., L.C.L., and K.G.A.), NIH NIAID 3U19AI135995-03S2 (K.G.A.), U19AI135995 (K.G.A.), U01AI151812 (K.G.A.), NIH NCATS UL1TR002550 (K.G.A.), the Conrad Prebys Foundation (K.G.A.), NIH 5T32AI007244-38 (J.I.L.), NIH Pioneer Grant 1DP1AT010885 (R.K), NSF RAPID 2029069 (R.K.), San Diego County Health and Human Services Agency (R.F.M), NIH S10OD026929 (K.J.). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of California San Diego Institutional Review Boards (IRB) provided human subject protection oversight of the of the data obtained by the EXCITE lab for the campus clinical samples (IRB approval #210699, #200477). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and any sample identifiers included were de-identified. The wastewater component of this project was discussed with our Institutional Review Board, and was not deemed to be human subject research, as it did not record personally identifiable information.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability and relevant links provided in the manuscript https://searchcovid.info/dashboards/wastewater-surveillance/